Form 990 for tax year 2022
Filed by DIABETES RESEARCH INSTITUTE FOUNDATION INC.
Totals
- Total revenue
- $7,129,662
- Total expenses
- $11,554,214
- Contributions and grants received
- $3,261,763
- Grants paid
- $5,209,284
- Program service revenue
- $0
- Investment income
- $1,344,179
- Other revenue
- $2,523,720
- Total assets, end of year
- $28,164,828
- Total liabilities, end of year
- $799,974
- Net assets or fund balances, end of year
- $27,364,854
- Program services expenses (Part IX)
- $6,907,088
- Management and general expenses
- $2,071,601
- Fundraising expenses
- $2,575,525
- Program service expenses (Part III)
- $6,907,088
Program services were 59.8% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1f · All other contributions, gifts and grants
$3,261,763
-
1g · Noncash contributions included above
$50,762
-
3 · Investment income
total $737,942 · excluded $737,942
-
4 · Income from investment of tax-exempt bond proceeds
total $0
-
5 · Royalties
total $0
-
6c · Rental income or loss
real property $0 · personal property $0
-
6d · Net rental income or loss
total $0
-
7a · Gross sales of assets other than inventory
securities $4,976,717
-
7b · Less cost or other basis and sales expenses
securities $4,370,480
-
7c · Gain or loss
securities $606,237
-
7d · Net gain or loss
total $606,237 · excluded $606,237
-
8a · Fundraising events: gross income
$5,010,196
-
8b · Fundraising events: direct expenses
$2,486,476
-
8c · Net income from fundraising events
total $2,523,720 · excluded $2,523,720
-
9a · Gaming: gross income
$0
-
9b · Gaming: direct expenses
$0
-
9c · Net income from gaming
total $0
-
10a · Gross sales of inventory
$0
-
10b · Cost of goods sold
$0
-
10c · Net income from sales of inventory
total $0
-
11e · Other revenue, total
$0
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $5,209,284 · program services $5,209,284
-
2 · Grants to domestic individuals
total $0
-
3 · Grants to foreign organizations and individuals
total $0
-
4 · Benefits paid to or for members
total $0
-
5 · Compensation of officers, directors and key employees
total $588,582 · program services $157,497 · management and general $153,175 · fundraising $277,910
-
6 · Compensation of disqualified persons
total $0
-
7 · Other salaries and wages
total $2,611,137 · program services $920,786 · management and general $497,068 · fundraising $1,193,283
-
8 · Pension plan contributions
total $105,170 · program services $7,330 · management and general $23,715 · fundraising $74,125
-
9 · Other employee benefits
total $206,418 · program services $1,451 · management and general $81,775 · fundraising $123,192
-
10 · Payroll taxes
total $158,955 · program services $9,562 · management and general $54,822 · fundraising $94,571
-
11a · Fees: management
total $0
-
11b · Fees: legal
total $13,644 · program services $0 · management and general $10,994 · fundraising $2,650
-
11c · Fees: accounting
total $102,232 · program services $0 · management and general $102,232 · fundraising $0
-
11d · Fees: lobbying
total $0
-
11e · Fees: professional fundraising services
total $0
-
11f · Fees: investment management
total $187,037 · management and general $187,037
-
11g · Fees: other
total $395,664 · program services $99,074 · management and general $126,336 · fundraising $170,254
-
12 · Advertising and promotion
total $151,951 · program services $149,051 · management and general $50 · fundraising $2,850
-
13 · Office expenses
total $201,447 · program services $3,069 · management and general $29,159 · fundraising $169,219
-
14 · Information technology
total $61,716 · program services $1,243 · management and general $57,488 · fundraising $2,985
-
15 · Royalties
total $0
-
16 · Occupancy
total $248,813 · program services $15,355 · management and general $203,587 · fundraising $29,871
-
17 · Travel
total $64,219 · program services $4,081 · management and general $6,718 · fundraising $53,420
-
18 · Travel or entertainment for public officials
total $0
-
19 · Conferences, conventions and meetings
total $1,155 · program services $150 · fundraising $1,005
-
20 · Interest
total $0
-
21 · Payments to affiliates
total $0
-
22 · Depreciation, depletion and amortization
total $116,718 · program services $4,018 · management and general $105,644 · fundraising $7,056
-
23 · Insurance
total $45,585 · management and general $45,585
-
24a · Other expenses: CONTRACTUAL SERVICES
total $572,191 · program services $163,391 · management and general $73,172 · fundraising $335,628
-
24b · Other expenses: PRINTING AND GRAPHICS
total $301,697 · program services $12,595 · management and general $1,960 · fundraising $287,142
-
24c · Other expenses: MERCHANT FEES
total $52,633 · management and general $52,633
-
24d · Other expenses: DUES AND SUBSCRIPTIONS
total $39,319 · program services $7,475 · management and general $2,387 · fundraising $29,457
-
24e · All other expenses
total $118,647 · program services $141,676 · management and general $256,064 · fundraising -$279,093
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $2,870,808 · end of year $3,061,074
-
2 · Savings and temporary cash investments
beginning of year $0 · end of year $0
-
3 · Pledges and grants receivable
beginning of year $3,251,526 · end of year $1,804,835
-
4 · Accounts receivable
beginning of year $305,202 · end of year $0
-
5 · Loans and receivables from officers and key people
beginning of year $0 · end of year $0
-
6 · Loans and receivables from disqualified persons
beginning of year $0 · end of year $0
-
7 · Other notes and loans receivable
beginning of year $0 · end of year $0
-
8 · Inventories for sale or use
beginning of year $0 · end of year $0
-
9 · Prepaid expenses and deferred charges
beginning of year $0 · end of year $921,080
-
10a · Land, buildings and equipment: cost or other basis
$649,037
-
10b · Land, buildings and equipment: accumulated depreciation
$667,206
-
10c · Land, buildings and equipment, net
beginning of year $122,965 · end of year -$18,169
-
11 · Investments: publicly traded securities
beginning of year $24,863,725 · end of year $22,315,075
-
12 · Investments: other securities
beginning of year $0 · end of year $0
-
13 · Investments: program-related
beginning of year $0 · end of year $0
-
14 · Intangible assets
beginning of year $0 · end of year $0
-
15 · Other assets
beginning of year $830,411 · end of year $80,933
-
17 · Accounts payable and accrued expenses
beginning of year $1,373,041 · end of year $799,974
-
18 · Grants payable
beginning of year $0 · end of year $0
-
19 · Deferred revenue
beginning of year $0 · end of year $0
-
20 · Tax-exempt bond liabilities
beginning of year $0 · end of year $0
-
21 · Escrow or custodial account liability
beginning of year $0 · end of year $0
-
22 · Loans and payables to officers and key people
beginning of year $0 · end of year $0
-
23 · Secured mortgages and notes payable
beginning of year $0 · end of year $0
-
24 · Unsecured notes and loans payable
beginning of year $0 · end of year $0
-
25 · Other liabilities
beginning of year $0 · end of year $0
-
27 · Net assets without donor restrictions
beginning of year $10,080,546 · end of year $6,573,804
-
28 · Net assets with donor restrictions
beginning of year $20,791,050 · end of year $20,791,050
Mission and programs · 2022
Mission
TO PROVIDE THE DIABETES RESEARCH INSTITUTE WITH THE FUNDING TO CURE DIABETES NOW.
-
THE DIABETES RESEARCH INSTITUTE FOUNDATION FUNDS BASIC, PRE-CLINICAL AND PATIENT-BASED RESEARCH STUDIES, INCLUDING FIVE PHASE I/II CLINICAL STUDIES, SEVERAL OF WHICH ARE SIMULTANEOUSLY UNDERWAY AT THE DIABETES RESEARCH INSTITUTE (DRI), WITH THE OTHERS PENDING COMMENCEMENT. THE ONGOING 'ISLETS IN THE OMENTUM' BIOHUB TRIAL WAS THE FIRST STEP IN TESTING THE SAFETY AND EFFICACY OF INSULIN-PRODUCING CELLS TRANSPLANTED WITHIN A TISSUE-ENGINEERED PLATFORM IN A DIFFERENT SITE THAN THE LIVER, THE TRADITIONAL TRANSPLANT SITE. FOUNDATION FUNDING HAS ALLOWED THE DRI'S CLINICAL CELL TRANSPLANT TEAM TO CONTACT AND SCREEN MORE THAN 1,200 CANDIDATES FOR THIS INNOVATIVE PILOT TRIAL, SEVERAL OF WHOM WERE SELECTED AND PLACED ON THE WAITING LIST TO UNDERGO THE PROCEDURE PENDING THE AVAILABILITY OF A MATCHING DONOR ORGAN. OTHER ALTERNATIVE TRANSPLANT SITES CONTINUE TO BE EXPLORED. DRIF FUNDING ALSO SUPPORTS THE CONTINUED FOLLOW-UP AND CARE OF THE DRI'S ISLET TRANSPLANT PATIENTS WHO HAVE PARTICIPATED IN PREVIOUS CLINICAL TRIALS. MANY OF THESE HAVE REMAINED INSULIN INDEPENDENT FOR A VARYING NUMBER OF YEARS. THIS PAST YEAR, DRI PRESENTED DATA SHOWING THAT THEIR ISLET TRANSPLANT PATIENTS WHO WERE STILL FREE FROM INSULIN FOR AN AVERAGE OF 10 YEARS HAD NEAR-NORMAL BLOOD SUGAR LEVELS, SIMILAR TO THOSE WITHOUT DIABETES. DRIF HAS ALSO FUNDED DRI RESEARCH PROJECTS THAT FOCUS ON ESTABLISHING IMMUNE TOLERANCE AND REVERSING AUTOIMMUNITY, THE BODY'S DESTRUCTION OF THE INSULIN-PRODUCING CELLS WHICH CAUSED THE ONSET OF THE DISEASE. SEVERAL OF THE CLINICAL TRIALS ADDRESS THESE CHALLENGES WHILE OTHER RESEARCH EARLIER IN THE PIPELINE REMAINS UNDERWAY. ANOTHER MAJOR RESEARCH AREA THAT DRIF SUPPORTS IS THE DEVELOPMENT OF AN UNLIMITED SUPPLY OF INSULIN-PRODUCING CELLS. DRIF-FUNDED STUDIES HAVE LED TO SIGNIFICANT PROGRESS IN STIMULATING THE REGENERATION OF PANCREATIC STEM CELLS INTO INSULIN-PRODUCING CELLS USING A SINGLE FDA-APPROVED MOLECULE. THIS SIGNIFICANT FINDING OPENS TO DOOR TO A NATURAL CELL SUPPLY BANK WITHIN THE PATIENT'S BODY, ADDRESSING SEVERAL ONGOING CHALLENGES FOR CURING THE DISEASE. THE DRIF HAS FUNDED INTERNATIONAL RESEARCHER TRAINING AND KEY COLLABORATIVE PROGRAMS THAT HELP ACCELERATE RESEARCH PROGRESS THROUGH THE SHARING OF IDEAS AND ADVANCEMENTS. ALSO, DRIF-FUNDED RESEARCH EQUIPMENT WAS USED IN A PHASE III MULTI-CENTER CLINICAL ISLET TRANSPLANTATION TRIAL. THE RESULTING DATA DEMONSTRATED THAT ISLET TRANSPLANTATION IS EFFECTIVE IN PREVENTING SEVERE HYPOGLYCEMIA - DANGEROUSLY LOW BLOOD SUGAR LEVELS - WHICH REPRESENTS A PARTICULARLY FEARED COMPLICATION IN TYPE 1 DIABETES THAT CAN LEAD TO SEIZURES, LOSS OF CONSCIOUSNESS AND EVEN DEATH. IMPORTANTLY, THE RESULTS OF THIS PHASE III TRIAL PAVE THE WAY FOR ISLET TRANSPLANTATION TO BECOME AN FDA-APPROVED TREATMENT FOR PATIENTS WITH DIABETES AND ONE THAT WOULD BE ELIGIBLE FOR INSURANCE REIMBURSEMENT. KEY FUNDED RESEARCH AREAS INCLUDE CELL-BASED THERAPIES FOR ISLET REPLACEMENT, IMMUNE TOLERANCE, IMMUNE REGULATION, REGENERATIVE MEDICINE, AND STEM CELL RESEARCH, AMONG OTHERS, TO RESTORE BIOLOGICAL INSULIN PRODUCTION. TOGETHER WITH OTHER DIABETES ADVOCACY ORGANIZATIONS, THE DRIF HAS APPEARED BEFORE CONGRESS TO REQUEST INCREASED FUNDING FOR DIABETES RESEARCH, AND HAS MADE RECOMMENDATIONS ON THE FUTURE DIRECTION OF RESEARCH APPROPRIATIONS. DRIF ALSO HOSTS AND PARTICIPATES IN A VARIETY OF INFORMATIONAL WORKSHOPS FOR PEOPLE WITH DIABETES AND THEIR FAMILIES FOCUSING ON THE LATEST ADVANCES TOWARD A CURE AND THE NEWEST DIABETES MANAGEMENT TECHNIQUES. THROUGH ITS WEBSITE DIABETESRESEARCH.ORG, THE DRIF PROVIDES 'NEWS YOU CAN USERESEARCH UPDATES FOR THOSE LIVING WITH DIABETES AND THEIR FAMILY MEMBERS IN THE FORM OF E-NEWSLETTERS, VIDEOS, EMAIL ANNOUNCEMENTS AND INFORMATION VIA SOCIAL MEDIA.
Expenses $6,249,645 · Grants $5,209,284
-
COMMUNITY DIABETES EDUCATION. THE DIABETES RESEARCH INSTITUTE FOUNDATION PROVIDES INFORMATION TO THE PUBLIC VIA ITS WEBSITE LITERATURE, SPEAKERS AND HOSTING AN ANNUAL DIABETES RESEARCH CONFERENCE, PRINT INTERVIEWS AND TOLL FREE NUMBER 800-321-3437. THE PUBLIC GAINS KNOWLEDGE ABOUT DIABETES, DIABETES CARE AND RESEARCH TOWARDS FINDING A CURE FOR DIABETES.
Expenses $657,443
As filed on the 2022 return. The filer continues this part on Schedule O, which is not shown here.
Listed in Part VII
-
Sean KramerSEAN KRAMER
CHIEF EXECUTIVE OFFICER
- Total calculated
- $251,642
- From this org
- $237,501
- From related orgs
- $0
- Other
- $14,141
- Hours/week
- 50
Schedule J breakdown matched by us
- Base
- $237,501
- Bonus
- $0
- Other
- $0
- Deferred
- $0
- Nontaxable benefits
- $14,141
- Filer's total
- $251,642
-
Amy PowersAMY POWERS
CHIEF DEVELOPMENT OFFICER
- Total calculated
- $235,322
- From this org
- $208,322
- From related orgs
- $0
- Other
- $27,000
- Hours/week
- 50
Schedule J breakdown matched by us
- Base
- $208,322
- Bonus
- $0
- Other
- $0
- Deferred
- $0
- Nontaxable benefits
- $27,000
- Filer's total
- $235,322
-
Jill Shapiro-MillerJILL SHAPIRO-MILLER
EXECUTIVE VICE PRESIDENT
- Total calculated
- $224,952
- From this org
- $197,952
- From related orgs
- $0
- Other
- $27,000
- Hours/week
- 50
Schedule J breakdown matched by us
- Base
- $197,952
- Bonus
- $0
- Other
- $0
- Deferred
- $0
- Nontaxable benefits
- $27,000
- Filer's total
- $224,952
-
Thomas KarlyaTHOMAS KARLYA
EXECUTIVE VICE PRESIDENT
- Total calculated
- $210,372
- From this org
- $197,952
- From related orgs
- $0
- Other
- $12,420
- Hours/week
- 50
Schedule J breakdown matched by us
- Base
- $197,952
- Bonus
- $0
- Other
- $0
- Deferred
- $0
- Nontaxable benefits
- $12,420
- Filer's total
- $210,372
-
Samantha DavisSAMANTHA DAVIS
CHIEF FINANCIAL OFFICER
- Total calculated
- $151,470
- From this org
- $142,759
- From related orgs
- $0
- Other
- $8,711
- Hours/week
- 60
Schedule J breakdown matched by us
- Base
- $142,759
- Bonus
- $0
- Other
- $0
- Deferred
- $0
- Nontaxable benefits
- $8,711
- Filer's total
- $151,470
-
Jessica SinnesJESSICA SINNES
ASSISTANT VP, PHILANTHROPY
- Total calculated
- $140,095
- From this org
- $122,890
- From related orgs
- $0
- Other
- $17,205
- Hours/week
- 50
-
Stephanie LanzaSTEPHANIE LANZA
DIRECTOR STRATEGIC PARTNERSHIP
- Total calculated
- $134,733
- From this org
- $122,228
- From related orgs
- $0
- Other
- $12,505
- Hours/week
- 50
-
MacKenzie CraneMACKENZIE CRANE
DIRECTOR OF MAJOR GIFTS
- Total calculated
- $123,872
- From this org
- $116,822
- From related orgs
- $0
- Other
- $7,050
- Hours/week
- 50
-
William FishlingerWILLIAM FISHLINGER
BOARD CHAIRMAN
- Total calculated
- $0
- Hours/week
- 5
-
John DoscasJOHN DOSCAS
VICE CHAIRMAN
- Total calculated
- $0
- Hours/week
- 5
-
Harold Doran JrHAROLD DORAN JR
IMMEDIATE PAST BOARD CHAIRMAN
- Total calculated
- $0
- Hours/week
- 5
-
Bruce SiegelBRUCE SIEGEL
TREASURER
- Total calculated
- $0
- Hours/week
- 5
-
Matthew StubbsMATTHEW STUBBS
SECRETARY
- Total calculated
- $0
- Hours/week
- 5
-
Marc S GoodmanMARC S GOODMAN
AT LARGE
- Total calculated
- $0
- Hours/week
- 5
-
Charles RizzoCHARLES RIZZO
AT LARGE
- Total calculated
- $0
- Hours/week
- 5
-
Marlene BergMARLENE BERG
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Ronald DarlingRONALD DARLING
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Marc GoldfarbMARC GOLDFARB
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Esther GoodmanESTHER GOODMAN
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Bonnie InserraBONNIE INSERRA
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Lindsey Inserra-HughesLINDSEY INSERRA-HUGHES
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Eleanor KosowELEANOR KOSOW
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Scarlett LeungSCARLETT LEUNG
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Ramon PooRAMON POO
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Stephen RizzoSTEPHEN RIZZO
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Ricardo SalmonRICARDO SALMON
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Sam TalbotSAM TALBOT
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Richard TonkinsonRICHARD TONKINSON
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Jill VinerJILL VINER
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Bruce WallerBRUCE WALLER
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
- 3 · Form 990 of other organizations
- 3 · Written employment contract
- 3 · Compensation survey or study
- 3 · Approval by the board or compensation committee
Answered no
- 4a · Severance or change-of-control payment
- 4b · Supplemental nonqualified retirement plan
- 4c · Equity-based compensation arrangement
- 5a · Pay contingent on this organization's revenues
- 5b · Pay contingent on a related organization's revenues
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 7 · Other non-fixed payments
- 8 · Paid under the initial-contract exception
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
-
RESEARCH
Related organizations on this return
Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.
-
DIABETES RESEARCH INSTITUTE UK
501(C)(3) · DONATIONS · UK · controlled entity
Directly controlled by DRIF
Provenance
- Return type
- form_990
- Tax year
- 2022
- Filed
- 30 April 2024
- IRS schema version
- 2022v5.0
- Source object
- 202411359349301511
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.